Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

AI could help spot dengue without expensive lab tests

NCT ID NCT07432061

First seen Feb 28, 2026 · Last updated Jun 23, 2026 · Updated 17 times

Summary

This completed study tested whether machine learning could predict dengue and severe dengue using electronic health records from 1,000 patients in Thailand and Vietnam. The goal was to create a low-cost tool that works even when lab tests are unavailable. Researchers used vital signs and basic blood counts to train the AI, aiming to improve diagnosis in areas where dengue is common.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PREDICTION are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Locations

  • Hospital for Tropical Diseases, Faculty of Tropical Medicine

    Bangkok, 10400, Thailand

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to

If successful, this could lead to a low-cost AI tool that helps doctors in resource-limited areas quickly diagnose dengue and predict who might get severely ill.

What could go wrong

This was a retrospective data analysis, not a live trial. The models may not work as well in real-world clinics or in different regions, and missing data could limit accuracy.

Conditions

The condition(s) this trial relates to.

dengue disease

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.